Compass Therapeutics Inc

CMPXNASDAQ · USD
1.85USD0.00 (+1.10%)
215

Compass Therapeutics Inc (CMPX) Option Chain

As of September 17, 2026, Compass Therapeutics Inc is trading at $1.85, a +1.10% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 116.3%. IV Rank is 25%.

Read more

Tracking the CMPX option chain helps you see every strike and expiry on Compass Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Compass Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CMPX options activity at a glance. Use our scanner to monitor the CMPX option chain in real time and filter for the CMPX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CMPX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CMPX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CMPX stock options are being actively traded and where they are not.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1.

The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Compass Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CMPX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CMPX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile26.59% Subdued
  • Market cap (M$)333
  • 52 weeks high-73.11%
  • 52 weeks low14.91%
  • Analyst recommendationStrong Buy
    1.13
  • Target price$8.92
    382.16% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-04
  • P/E
  • Future P/E
  • EPS (ttm)-0.40
  • EPS growth next 5 years19.58%

As of September 17, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.00000.021.351.051.700.50-72.970.050.000.0500100.00
0.00110.100.850.651.251.00-45.950.050.000.0500100.00
0.00000.020.350.050.701.50-18.920.750.000.7500100.00
94.341,566100.150.000.152.00+8.110.100.350.150.0801155.66
100.006,66830.200.000.203.00+62.160.801.451.15-0.02000.00

As of September 17, 2026

Scan the full option chain in one place

Browse the full CMPX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial